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The yes-associated protein (YAP) is a key effector of the mammalian Hippo signaling pathway. YAP has
eight known alternately spliced isoforms and these are widely expressed across multiple tissues. Variable
effects have been ascribed to different YAP isoforms by inducing their expression in cells, but whether
these differences are due to variability in the transcriptional potency of individual YAP isoforms has not
been addressed. Indeed a systematic comparison of the transcriptional potencies of YAP isoforms has not
been done. To address this, using overexpression and transcriptional reporter analyses we investigated
the transcriptional activities of several human YAP isoforms and determined the effects of the splice
variant insertions within the transactivation domain on its transcriptional potency. Utilising full-length
coding sequence constructs we determined that the number of WW domains and disruption of the
leucine zipper motif within YAP’s transactivation domain both contribute to transcriptional activity.
Notably, disruption of YAP’s leucine zipper had a greater effect on transcriptional activity than the ab-
sence of the second WW domain. Using GAL4-YAP transcriptional activation domain fusion proteins we
found that disruption of the leucine zipper signiﬁcantly decreased YAP’s transcriptional activity in sev-
eral cell lines. Our data indicates that expression of different YAP isoforms with varying transcriptional
potencies may enable ﬁne control of Hippo pathway signaling. Furthermore the speciﬁc isoform being
utilised should be taken into consideration when interpreting published data or when designing ex-
periments to ascribe YAP’s function.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Yes-associated protein (YAP) is a transcriptional co-activator [1]
that functions as an effector for the mammalian Hippo signaling
pathway [2–5]. YAP promotes growth and cell survival by reg-
ulating genes involved in proliferation including cyclin D1 [6],
survivin [2], connective tissue growth factor [7], and amphiregulin
[8]. YAP interacts with many proteins via several protein-interac-
tion domains to facilitate nuclear localisation, DNA-binding, andB.V. This is an open access article u
ranscriptional activation do-
use YAP; WT, wild-type; Con,
-Lab, National University of
gapore.
Edmondson),
uwa.edu.au (B.A. Callus).recruitment of transcription factors (reviewed in [9]).
The human YAP1 gene comprises nine exons, generating at
least eight alternatively spliced isoforms, all of which are detect-
able as mRNA in several human tissues [10]. The YAP protein
comprises multiple domains that enable binding to a variety of
proteins. Exons 1–3 encode the N-terminal region including the
TEAD-binding and ﬁrst WW domains, whereas YAP’s second WW
domain, which is only present in hYAP1-2 isoforms (Fig. 1), is
encoded by exon 4. Since YAP does not harbour an intrinsic DNA-
binding domain it relies on association with DNA-binding tran-
scription factors to co-activate target genes. TEAD proteins (1–4)
are the major DNA-binding factors for YAP, associating with YAP
via its TEAD-binding domain [11,12]. However several other fac-
tors have been identiﬁed that utilise YAP’s WW domains for
binding e.g., p73 [13] and ErbB-4 [14].
As a co-activator of transcription, YAP must localize to the
nucleus and recruit general transcription factors to activate gene
expression. The C-terminal region of YAP, rich in serine, threonine
and acidic amino acids, acts as a strong transcription activationnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Gene structure and transcriptional activation domain variations of human YAP isoforms. The eight human YAP1 isoforms are encoded by nine exons. Exons 1–3
encode the N-terminal region including the TEAD-binding (yellow) and ﬁrst WW domain (green), whereas the second WW domain, present only in hYAP1-2 isoforms, is
encoded by exon 4. Exons 5–9 encode the SH3-binding region (red) and the C-terminus of YAP, with exons 5B (extended transcript of exon 5, purple) and 6 (orange) encoding
an additional 4 and 16 amino acids, respectively. The presence or absence of these additional amino acids within the leucine zipper motif (crimson bar) of the transcriptional
activation domain (blue), give rise to the α, β, γ, and δ isoforms as indicated. Inset: the position of the ﬁve leucine residues that form the leucine zipper are shown in red.
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possess a traditional nuclear localisation signal, thus relies on as-
sociation with other proteins via its PDZ-binding motif to mediate
nuclear localisation [15,16]. YAP’s C-terminal TAD and PDZ-binding
motifs are encoded by exons 5–9.
Exon 5 has an alternate splice donor site, generating an ex-
tended transcript (exon 5B) encoding an additional four amino
acids (VRPQ), whereas exon 6 speciﬁes an additional 16 amino
acids (AMRNINPSTANSPKCQ). Exons 5B and 6, which either alone
or in combination are present in six out of eight human YAP
(hYAP) isoforms, insert within the leucine zipper motif (also
known as the coiled-coil motif) in YAP’s TAD to generate the β, γ,
and δ isoforms [10]. In contrast, the α isoform does not contain
any insertions in the TAD region. The leucine zipper motif, com-
prising ﬁve highly-conserved leucine residues at every seventh
position, mediates protein-protein interactions [17].
Standardised nomenclature for hYAP isoforms was proposed by
Gaffney et al. [10], and further simpliﬁed [18], as it was acknowl-
edged that publications reporting use of “hYAP cDNA” for func-
tional studies actually used one of several isoforms, making it
difﬁcult to compare across studies. For example, numerous pub-
lications reported using hYAP1-2γ (also referred to as YAP1-504
aa) [2–5,19,20] and one study used hYAP1-2α (YAP1-488 aa) [21].
This is signiﬁcant since overexpression of hYAP1-2γ promoted
cellular proliferation, EMT, colony formation, protection from
apoptosis in MCF10A cells in vitro [3,5,20], and liver overgrowth
in vivo [2], whereas overexpression of hYAP1-2α in the UMSCC-
11A squamous cell carcinoma line increased cell death [21]. Whilst
the differences in YAP function may be due to cellular context, it
cannot be discounted that the speciﬁc YAP isoform utilised, or the
combination, may contribute to this result.
Other studies directly compared hYAP isoforms to draw con-
clusions about the functional importance of different YAP do-
mains. For example, comparison of their transcriptional activities
revealed that hYAP1-2α is a stronger co-activator than hYAP1-1β
[14]. This was attributed to a higher afﬁnity for ErbB-4 mediated
by hYAP1-2α’s second WW domain. Similarly, signiﬁcant differ-
ences were identiﬁed between hYAP1-1 and -2 with regards to
promotion of apoptosis measured by PARP cleavage and p73 sta-
bilisation [22]. The contribution of YAP’s TAD sequence to tran-
scriptional activity was not evaluated in either study.
There is sufﬁcient evidence indicating that YAP’s protein-pro-
tein interaction domains contribute signiﬁcantly to its transcrip-
tional activity. Multiple studies have shown that critical mutationswithin one or both WW domains affect YAP’s transcriptional ac-
tivity [14,23,24], which may prevent YAP association with DNA-
binding transcription factors such as ErbB-4 and Runx2 [24] or its
interaction with other transcriptional modulators [25]. Subsequent
studies utilising Yorkie (YAP’s Drosophila orthologue) revealed that
the WW domains can recruit transcription enhancing factors in-
cluding Wbp2 [23]. It is generally accepted that YAP co-activates
transcription by recruiting members of the basal transcription
machinery, potentially via leucine zipper mediated interactions.
Notably, there are conﬂicting data on the functional requirement
of Yorkie and YAP C-terminus. In particular, Yorkie TAD was shown
to be superﬂuous to drive tissue growth in Drosophila, and YAP
TAD is not required to promote anchorage-independent growth or
resistance to contact inhibition in vitro [26]. Others have shown
that deletion of YAPs C-terminus decreased oncogenic functions
e.g., reduced xenograft expansion of ovarian cancer cells [27],
abolished EMT-like morphological changes induced by active YAP
in MCF10A cells [24], and failure to induce cellular proliferation in
the mouse retina in vivo [28].
Whilst previous studies have postulated that the insertion of
additional amino acids within the C-terminal TAD of YAP may
impair its transcriptional activity [10,14] a comprehensive analysis
of the relative transcriptional potency of C-terminal TAD variants
has not yet been done. To address this we analysed the tran-
scriptional activities of alternately spliced hYAP isoforms and de-
termined the effects of the C-terminal insertions in the TAD on its
transcriptional potency. This allowed us to deﬁne the contribution
of both the number of WW domains and an intact leucine zipper
to YAP’s transcriptional activity. Our data revealed that disruption
to the leucine zipper and the WW domains play key roles in de-
termining YAP transcriptional activity. Our results clearly demon-
strate that care must be taken when interpreting data generated
using different hYAP isoforms in multiple cell lines.2. Materials and methods
2.1. Plasmids and cDNAs
cDNAs for hYAP1-2α (YAP1-488 aa) and YAP1-1β (YAP1-454
aa) [10] and mouse YAP (mYAP, NCBI NM_009534.3) were ob-
tained from Marius Sudol (National University of Singapore).
hYAP1-2γ (YAP1-504 aa) was provided by Kieran Harvey (Peter
MacCallum Cancer Centre, VIC). pGT4Tluc Fireﬂy luciferase and
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philis (NICHHD/NIH). GFP/TetR/VP16 [30] was used as template to
generate GAL4–VP16.
mYAP constructs were generated by PCR using primers: 5′
GTAGGATCCATGGAGCCCGCGCAACA and 5′GTGTCTAGACTA-
TAACCACGTGAGAAATGGGCTCTGGGGAGCCAAGGGT for ΔTAD, 5′
GTGTCTAGACTAGCTTTCTTTATCTAGCTTGGTG for ΔPDZ, and 5′
GTAGGATCCATGCCTGCAGCT CAGCATCTC and 5′GTGTCTAGACTA-
TAACCACGTGAGAAAGCTTTC for ΔTEAD.
YAP C-termini comprising the TAD and PDZ-binding motif of mYAP,
and hYAP isoforms α, β and γ were ampliﬁed by PCR using primers: 5′
GTAGGATCCCAGGGAGGCGTCCTGGGTGGA and 5′GTGTCTAGACTA-
TAACCACGTGAGAAAGCTTTC for mYAP or 5′GTAGGATCCCAGGGAGGCGT-
CATGGGTGGCA and 5′GTGTCTAGACTATAACCATGTAAGAAAGCT for hYAP.
hYAPδ C-terminus was generated by overlapping PCR of hYAP1-2γ using
the same hYAP primers in combination with δ-speciﬁc primers: 5′SH3
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indicated. Size markers are shown in kilodaltons. (E) HEK293T cells were transfected
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kilodaltons. Vertical line indicates the samples were blotted on separate gels.GTGAGGCCACAGGCAATGCGGAATATCAATCCCAGCACAGC and 5′
GATATTCCGCATTGCCTGTGGCCTCACCTGCCGAAGCAGTTCTTGCTG.
The pFA-CMV-FLAG vector was generated by sub-cloning an-
nealed oligos encoding the FLAG sequence (DYKDDDDK) and an
additional BamHI recognition sequence 5′ to the EcoRI site, in-
frame into the pFA-CMV [31] vector using BglII and EcoRI. This
generated a new unique BamHI site 3′ of the FLAG sequence
(Fig. 4A). The TAD’s for all hYAP isoforms, mYAP and VP16 (amino
acids 413–490) were cloned in-frame into the pFA-CMV-FLAG
vector using unique BamHI/XbaI sites (Fig. 4A). GAL4–Stat5 was
described previously [31].
2.2. Cell culture
HEK293T cells were provided by David Vaux (Walter and Eliza
Hall Institute (WEHI), VIC). HeLa and D645 cells were obtainedPDZ
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TEAD-mediated transcriptional activity. (A) Schematic illustration of the pGT4Tluc
-tagged wild-type (WT), ΔTAD, ΔPDZ or ΔTEAD mYAP constructs (B), and pCI-HA-
vity was determined. Fireﬂy luciferase activity was normalised to Renilla luciferase
2, which was set to 100%. Data is presented as meanþSEM from three independent
y SDS-PAGE, transferred to membrane and immunoblotted for FLAG and β-Actin as
with pGT4Tluc (Control), mYAP or hYAP1-2α constructs, and pCI-HA-TEAD-2 (HA-
were immunoblotted for YAP and β-Actin as indicated. Size markers are shown in
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Cells were maintained in DMEM (Life Technologies, #11885) sup-
plemented with 10% (v/v) FBS, 50 U/mL penicillin G/50 mg/mL
streptomycin, and 2 mM L-glutamine in a humidiﬁed atmosphere
of 10% CO2 at 37 °C.
2.3. Luciferase assay
TEAD-dependent luciferase assays were performed by trans-
fecting sub-conﬂuent 12-well plates of HEK293T cells with 0.1 mg
pGT4Tluc, which harbours the ﬁreﬂy luciferase gene driven by four
tandem copies of the GTIIC site 30-mer containing the TEF-1 DNA
binding sites found in the polyomavirus F101 enhancer [29]
(Fig. 2A), 0.3 mg pF-5xUAS-MCS-W–SV40puro [32,33] expressing
full-length (entire coding sequence) wild-type (WT) or mutant
YAP constructs, 0.05 mg pRL-TK Renilla luciferase (internal control),
with or without 0.05 mg pCI-HA-TEAD-2, which can associate with
full-length mYAP and hYAP isoforms via their TEAD-binding do-
mains, and pUC13 to a total of 0.5 mg DNA per well using Effectene
(Qiagen #301425).
For GAL4 fusion experiments, sub-conﬂuent 12-well plates of
HEK293T cells were transfected with 0.1 mg pFR-Luc (Stratagene)
[31], 0.05 mg pFA-CMV-GAL4-FLAG YAP-TAD fusion constructs
(Fig. 4A), 0.1 mg pRL-TK, and pUC13 to a total of 0.5 mg DNA per
well using Effectene. For HeLa and D645 cell lines, cells were
transfected with 0.4 mg pFR-Luc, 0.2 mg pFA-CMV-FLAG YAP-TAD
fusion constructs, and 0.4 mg pRL-TK per well using ViaFect
(Promega).
Luciferase activity was measured after 24 h using the Dual
Luciferase Reporter Assay (Promega). Statistical signiﬁcance was
calculated by performing a one-way ANOVA with Tukey’s multiple
comparison test from at least three independent experiments.
2.4. Antibodies and immunoblotting
Anti-FLAG (#F1804) and Anti-β-actin (#A1978) were purchased
from Sigma-Aldrich (Castle Hill, NSW). Anti-HA (#2999) was
purchased from CST (Genesearch, Arundel, QLD). Lysates (20 mL)
were separated by SDS-PAGE and transferred to Hybond C mem-
brane (GE, Castle Hill, NSW). Membranes were immunoblotted
with antibodies and detected with chemiluminescence as de-
scribed [34].3. Results
3.1. YAP mutants lacking TAD and PDZ-binding domain have reduced
transcriptional activity
To conﬁrm that YAP’s TAD, PDZ-binding domain and TEAD-
binding domain are necessary for TEAD-mediated transcriptional
activity, mYAP deletion constructs (Fig. 2B) were utilised. Since
TEAD is the best-characterized oncogenic partner of YAP, the ac-
tivity of the mutants was assessed using a TEAD-dependent luci-
ferase assay [29] (Fig. 2A). Transfection of WT mYAP signiﬁcantly
increased luciferase activity 16-fold (po0.001) compared to the
luciferase construct alone (Control) (Fig. 2C). Despite comparable
expression by Western blot (Fig. 2D) theΔTAD andΔPDZ mutants
did not increase luciferase activity above basal levels (Fig. 2C). As
expected, ΔTEAD failed to increase luciferase activity above con-
trol levels and importantly this was not increased by co-transfec-
tion of TEAD2 indicating that luciferase expression with this re-
porter is speciﬁc for YAP-TEAD association. In contrast co-trans-
fecting cells with TEAD2 signiﬁcantly increased luciferase activity
for the WT (3.6-fold, po0.001) and ΔPDZ (5.9-fold, po0.05)
mYAP constructs (Fig. 2C). Notably, although luciferase activity forΔPDZ increased in the presence of TEAD2 it remained signiﬁcantly
lower (po0.001) than WT.
To conﬁrm that mYAP mutants may be used to infer informa-
tion about hYAP transcriptional activity, we compared the tran-
scriptional potency of mYAP to that of hYAP1-2α since they share
signiﬁcant amino acid sequence homology; TEAD-binding (96%),
PDZ-binding (100%) domains and TAD region (92%). No signiﬁcant
difference was observed in the relative luciferase activity between
mYAP and hYAP1-2α either in the presence of absence of co-
transfected TEAD2 (Fig. 2E). Together this data indicates that YAP’s
TAD, PDZ-binding and TEAD-binding domains are required for
TEAD-mediated transcriptional activity, and that exogenously ex-
pressed TEAD2 can functionally associate with both mYAP and
hYAP to activate transcription.
3.2. YAP’s tandem WW domains and leucine zipper motif contribute
to transcriptional activity
To determine whether the number of WW domain/s (single
versus tandem) and interruption of the leucine zipper motif im-
pacts YAP’s transcriptional activity, three hYAP isoforms with
combinations of these features were compared using the TEAD
reporter assay (Fig. 3). Transfection of hYAP1-1α and hYAP1-2α
signiﬁcantly increased luciferase activity 5.6-fold (po0.001) and
14.3-fold (po0.001) respectively compared to luciferase alone
(Control). In contrast, hYAP1-1β alone failed to increase luciferase
activity above control levels. Despite comparable expression levels
(Fig. 3B) the relative activity of hYAP1-1β was signiﬁcantly lower
than hYAP1-1α (3.2-fold lower po0.01) and hYAP1-2α (8.2-fold
po0.001) (Fig. 3A). Notably endogenous YAP was undetectable in
the HEK293T cells, thus our data is speciﬁc to the exogenous YAP
constructs.
As shown above, the TEAD reporter is speciﬁc for YAP-TEAD
association (Fig. 2). As expected, transfection of the luciferase re-
porter with TEAD2 resulted in a negligible increase in luciferase
activity, whereas co-transfection of TEAD2 signiﬁcantly increased
activity for hYAP1-2α (1.9-fold), hYAP1-1α (3.8-fold) and hYAP1-
1β (8.9-fold) (Fig. 3A). Despite the relatively large increase in lu-
ciferase activity for hYAP1-1β with TEAD2, this was still sig-
niﬁcantly lower than that measured for both hYAP1-1α (1.4-fold)
and hYAP1-2α (1.8-fold).
Notably, hYAP1-2α luciferase activity was consistently higher
than that of hYAP1-1αwith activity 2.5-fold higher without TEAD2
and 1.3-fold with TEAD2. Interestingly, this difference was not as
pronounced as that between hYAP1-1α and hYAP1-1β which was
3.2-fold higher in the absence of TEAD2 but only 1.4-fold in its
presence (Fig. 3A). These data indicate that both a single WW
domain and disruption of the leucine zipper reduce YAP’s tran-
scriptional activity. Furthermore, that disruption of the leucine
zipper within YAP’s TAD has a possibly greater effect than the
absence of tandemWW domains especially when TEAD is limiting.
3.3. Disruption of YAP’s leucine zipper motif reduces its transcrip-
tional co-activator function
To directly examine the effect of a disrupted leucine zipper
motif on YAP’s transcriptional potency, the C-terminal region for
each hYAP isoform (α, β, γ and δ) and mYAP comprising the TAD
and PDZ-binding motif were fused to a FLAG-tagged GAL4-DNA
binding domain construct (Fig. 4A) and GAL4-dependent luciferase
reporter assays were performed in several cell lines (Fig. 4).
Transfection of the GAL4-YAP TAD fusion constructs signiﬁcantly
increased luciferase activity above the luciferase alone (Con) and
empty-vector (EV) negative controls and the Stat5a positive con-
trol [31]. Luciferase activity stimulated by the VP16 TAD [1] was
comparable with that of the YAP-fusions but more variable, being
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being higher in D645 (Fig. 4C) and HeLa cells (Fig. 4D). Transfec-
tion of YAPα resulted in signiﬁcantly higher luciferase activity
compared to YAPβ (1.3-fold po0.001), YAPγ (1.3-fold po0.01) and
YAPδ (1.5-fold po0.001) in HEK293T cells (Fig. 4B). Interestingly,
YAPm, the mouse equivalent of YAPα, increased luciferase activity
to a similar extent. Western blot analyses indicated that YAPα and
to some extent YAPm and YAPβ were expressed at lower levels
than YAPγ and YAPδ (Fig. 4B), which may be due to differences in
the stability of the various isoforms, suggesting that differences in
transcriptional activity between YAPα and other isoforms with
disrupted leucine zipper motifs are underestimated here. It is also
worth noting that none of the GAL4-fusion constructs were de-
tected by Western blot in either D645 or HeLa cells.
Consistent with HEK293T data, YAPα and YAPm induced luci-
ferase activity to a similar extent and both were signiﬁcantly
higher than YAPβ, YAPγ and YAPδ in D645 (Fig. 4C) and HeLa
(Fig. 4D) cells, with the exception that YAPβ was not signiﬁcantly
different to YAPα in HeLa cells. In general the differences in activity
for YAPβ, YAPγ and YAPδ compared to YAPα were more pro-
nounced in the D645 cells (2.0- to 2.6-fold decrease) compared to
the HEK293Ts (1.3- to 1.5-fold decrease), and less so in HeLa cells
(1.3-fold decrease). Notably, no signiﬁcant difference was observed
between YAPβ, YAPγ and YAPδ in all cell lines tested (Fig. 4B and C).Together, these data support our ﬁndings obtained using the entire
coding sequence of YAP whereby disruption of YAP’s leucine zip-
per motif decreases its transcriptional co-activator activity
(Fig. 3A).
Intriguingly, the difference in luciferase activity between full-
length proteins (hYAP1-1α versus hYAP1-1β) (Fig. 3A) was more
pronounced than for the GAL4-YAP TAD fusions (YAPα versus YAPβ)
(Fig. 4B) (3.2-fold compared to 1.3-fold decrease in activity in
HEK293T cells), despite both varying only by insertion of four
amino acids within the leucine zipper motif. This may reﬂect dif-
ferences in the comparative expression of the different constructs
or the luciferase system used.4. Discussion
Using overexpression and transcriptional reporter analyses, this
study represents the ﬁrst detailed analysis of the transcriptional
potency of the TAD from alternately spliced C-terminal YAP iso-
forms. The existence of eight mammalian YAP isoforms suggests
that they have non-redundant roles within the cell. Indeed,
structural differences between YAP isoforms are predicted to affect
transcriptional activity and function [1,10,35], and this is sup-
ported by numerous publications that have identiﬁed differences
20
0
60
40
120
100
le
R
ivitca
esareficul
evita
)
%(
yt
FLAG
β-Actin
50
37
75 
***
**
***
*
*
***
Control
Mouse
Human
HEK293T
B
80
      Con   Stat5a   VP16     EV     YAPm   YAPα    YAPβ   YAPγ   YAPδ
40
0
120
80
200
160
R
e
tal
evi
l
cu
fi
esare
tca
tivi
y
)
%(
**
**
***
*
*
***
C
20
60
100
140
180
      Con   Stat5a   VP16     EV     YAPm   YAPα    YAPβ   YAPγ   YAPδ
Control
Mouse
Human
D645
20
0
100
40
180
120
)
%(
ytivitca
esareficul
evitale
R
      Con   Stat5a   VP16     EV     YAPm   YAPα    YAPβ   YAPγ   YAPδ
*
*
*
***
***
D
60
80
140
160 Control
Mouse
Human
HeLa
A
GAL4 DBDpFA-CMV
MCS
FLAG
BamHI
YAP
XbaI
EcoRI
Fig. 4. Decreased transcriptional activity via disruption of YAP’s leucine zipper motif is not dependent on insert length. (A) Schematic illustration of the FLAG-tagged GAL4-
YAP TAD fusion constructs. The transactivation domain (blue) and PDZ-binding motif (black) for hYAP isoforms (α, β, γ and δ) and mYAP, were cloned 3′ to the FLAG sequence
using unique BamHI/XbaI sites. HEK293T (B), D645 (C) and HeLa (D) cells were transfected with pFR-Luc (Con), together with FLAG-tagged empty vector (EV), or the
C-terminal region of Stat5a, VP16, mYAP (YAPm), or the four hYAP isoforms (YAPα, YAPβ, YAPγ or YAPδ) fused to the GAL4 DNA-binding domain. After 24 h cells were harvested
and luciferase activity was determined. Fireﬂy luciferase activity was normalised to Renilla luciferase activity. The average luciferase activities were then normalised to YAPα,
which was set to 100%. Data is presented as meanþSEM from three (B) or four (C and D) independent experiments. *po0.05, **po0.01, ***po0.001. Lower panel (B): Cell
lysates were separated by SDS-PAGE, transferred to membrane and immunoblotted for FLAG and β-Actin as indicated. Size markers are shown in kilodaltons.
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sociation and PARP cleavage [22], Erb-B4 binding [14], transcrip-
tional activity [14,22,24], angiomotin association [36], and SHP2
binding [37].
Here we deﬁnitively demonstrate that the number of WW
domains and disruption of the leucine zipper both contribute to
YAP’s transcriptional activity. Interestingly, disruption of the leu-
cine zipper in the full-length proteins caused a relatively greater
loss in activity than the absence of a second WW domain. Notably,
the combination of these two factors had an additive effect on
YAP’s activity. This permits a range of YAP isoforms with varying
transcriptional potencies and abilities to associate with protein
partners via WW and leucine zipper domain-mediated
interactions.
YAP’s WW domains have two deﬁned functions: to bind non-
TEAD DNA-binding transcription factors e.g., p73 and ErbB-4
[13,14], and to recruit enhancers e.g., Wbp2 [23] or repressors [25]
of transcription. In this study a TEAD-dependent reporter was
utilised to assess transcriptional activity of full-length YAP. This
system is unable to assess non-TEAD mediated transcription, inwhich the presence of single or tandemWW domains could have a
more pronounced effect on YAP’s transcriptional activity due to
altered efﬁciency of association with DNA-binding proteins.
Since a functional leucine zipper structure is dependent on
precise spacing of leucine residues [17], it is expected that any
interruption of the leucine zipper should effectively disrupt the
motif. This is supported by the observation that the transcriptional
activities of YAPβ, YAPγ and YAPδ, with 4, 16 and 20 amino acid
insertions respectively, were similarly decreased in the cell lines
tested. It is important to note that a leucine zipper motif is not
essential for transactivation since neither TAZ nor Yorkie possess
one in their TADs. Interestingly, C-terminal homology between
Yorkie and YAP is low, although Yorkie and TAZ do harbour a
coiled-coil motif in their putative TAD (predicted using COILS:
http://embnet.vital-it.ch/software/COILS_form.html) via other
amino acids e.g., I-I-L-L-E in TAZ. Furthermore, as mentioned
above, YAP’s TAD is not required for anchorage-independent
growth of MCF10A and NIH3T3 cells in vitro [26]. However, YAP’s
TAD is necessary for particular oncogenic functions including cell
migration and invasion in vitro [26] and in vivo [27,28]. It is
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with other domains, to enhance transcriptional activity, enabling
ﬁne-tuning of YAP-mediated gene transcription by recruiting, or
stabilising the association with one or more co-factors, which is
dispensable for Yorkie in Drosophila [26].
Data obtained here using full-length YAP constructs suggests
the leucine zipper might stabilise the interaction with transcrip-
tional co-factors, possibly recruited via other domains e.g., WW
domains. Thus when using GAL4-TAD fusions these regulatory
factors would not be recruited into the transcriptional complex
and the effects of a disrupted leucine zipper are less obvious. It is
also worth noting that differences between the full-length YAP
isoforms examined were less apparent when TEAD2 was co-ex-
pressed. Here it is likely that exogenous YAP and TEAD2 are the
major contributors to transactivation of the luciferase reporter.
However, when TEAD proteins are limiting e.g., at endogenous
level, other regulatory co-factors may contribute signiﬁcantly to
transactivation. Under these conditions the effect of leucine zipper
disruption in addition to the presence of single or tandem WW
domains may be more pronounced. It is possible that the observed
differences in the absence of exogenous TEAD2 may also be con-
tributed to by subtle differences in binding afﬁnities with en-
dogenous TEAD proteins, or their relative abundance. However,
this is unlikely to account for the observed differences since all
YAP constructs were transfected at the same time and therefore
the abundance of all four endogenous TEAD proteins will be
equivalent across all samples.
The biological signiﬁcance of this data assumes that all YAP
isoforms are expressed as functional protein in vivo. Whilst
mRNAs of all hYAP isoforms are detectable across a range of tis-
sues and organs except leukocytes [10], it remains to be de-
termined whether all isoforms are functionally expressed and in
relative abundance. The differences in transcriptional activity re-
vealed in this study are notable, and suggests the expression of
different YAP isoforms may permit ﬁne-tuning of complex tran-
scriptional programmes that may result in different biological
outcomes. Future studies could proﬁle the speciﬁc expression of
hYAP isoforms, for example during development, to determine
whether this correlates with biologically relevant outputs e.g.,
target gene expression.
In conclusion, using overexpression and transcriptional re-
porter analyses this study demonstrates that hYAP isoforms have
signiﬁcantly different transcriptional activities. The presence of a
single or tandem WW domain combined with an intact or dis-
rupted leucine zipper domain contributes to YAP transcriptional
activity. Combined with the likelihood that these structural var-
iations will affect participation in a range of protein interactions,
this data conﬁrms that one cannot assume YAP’s eight known
isoforms function equivalently. Careful selection and comparison
of YAP isoforms and cellular context should be undertaken when
characterising or ascribing YAP’s function.Acknowledgements
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